Skip to main content
Premium Trial:

Request an Annual Quote

SurroMed and Biogen Extend Biomarker Collaboration

NEW YORK, March 11 (GenomeWeb News) - SurroMed and Biogen have extended their collaborative biomarker study, SurroMed said today.

 

SurroMed, based in Mountain View, Calif., will continue to analyze samples from multiple sclerosis patients treated with a drug from Biogen, using proteomics, metabolomics, and cytometry, to identify biomarkers.

 

Both companies started their collaboration in 2002 to characterize responses to Biogen's drug in patients.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.